All data are based on the daily closing price as of November 11, 2026
g
Grape King Bio
1707.TW
2.40 USD
-0.01
-0.41%
Overview
Last close
2.40 usd
Market cap
354.79M usd
52 week high
4.63 usd
52 week low
2.40 usd
Target price
4.2 usd
Valuation
P/E
10.2341
Forward P/E
17.3611
Price/Sales
1.1518
Price/Book Value
1.1474
Enterprise Value
250.49M usd
EV/Revenue
0.8132
EV/EBITDA
2.986
Key financials
Revenue TTM
308.03M usd
Gross Profit TTM
226.30M usd
EBITDA TTM
75.94M usd
Earnings per Share
0.23 usd
Dividend
N/A usd
Total assets
471.87M usd
Net debt
-105.45M usd
About
Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distributors; Original Design Manufacturer/Original Equipment Manufacturer; and Sales Channel segments. The company provides health products and supplements; and microbial fermentation for mushroom mycelium, probiotics, and enzymes. It also offers functional ingredients for intestinal care, immunity regulation, liver care, brain health, eye care, weight control, feminine health, sensual health care, and others. It serves pharmaceutical preparations, finished drugs, oral liquids, and beverages and health foods. The company was founded in 1969 and is headquartered in Taoyuan City, Taiwan.